zintick

← ADMA Biologics (ADMA)

ADMA Biologics SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

  • 8-KNov. 4, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedADMA Biologics Q3 2026 adjusted EPS $0.23 beats $0.20 consensus on $141.1 million revenue; FY2026 revenue floor of $530 million sits below $535.3 million consensus

  • 8-KAug. 5, 2026, 4:10 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits